Delivery Order SPE2DB22D1017-SPE2DB25FE7TU

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,023.03, is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S, a pharmaceutical product, with a performance period through May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on August 15, 2023 for the supply of 4,561,819,646 units of ANUCORT-HC 25 MG SUPPOSITORY 12S. The order has a firm fixed-price ceiling value of $1,944.02 and a completion date of August 16, 2023. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.72, is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S medical products. The contract has an ultimate completion date of March 7, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S medical products. The $1,644.42 firm fixed-price contract has a completion date of June 1, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,036.45, is for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 15, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S medical supplies. The contract, with a ceiling value of $2,131.01, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on April 19, 2023, with a completion date of April 20, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA, covering a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,849.01 firm fixed-price delivery order is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,921.33, is a Firm Fixed Price Delivery Order for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S. The $1,844.15 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB23FN33C, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559583820 - ANUCORT-HC 25 MG SUPPOSITORY 12S, with a firm fixed price of $2,200.94 and a completion date of January 13, 2023. The contract is a delivery order and is not designated with a set-aside. Amerisourcebergen Drug Corp, a for-profit...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE7TU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S. The contract has a ceiling value of $1,296.35 and runs through October 24, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 1/22/25, 9:19 AM